Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | 2,908,257 | reported | 26 Jan 2026 | tx 19+8,981,772−1,179,571 |
| Ventas, Inc. | 26,181 | reported | 13 May 2026 | tx 12+26,331 |
| Neurogene Inc. | 25,000 | reported | 05 May 2020 | tx 6+88,500 |
| INTERMUNE INC | 0 | reported | 29 Sept 2014 | tx 37+389,000−409,000 |
| AveXis, Inc. | 0 | reported | 15 May 2018 | tx 17+271,000−1,009,300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2026 | GRANT_AWARD | Ventas, Inc. | 2,047 | 90.35 USD | |
| 21 Jul 2020 | PURCHASE | Ventas, Inc. | 27 | 34.21 USD | |
| 21 Jul 2020 | PURCHASE | Ventas, Inc. | 37 | 34.21 USD | |
| 20 Apr 2020 | PURCHASE | Ventas, Inc. | 50 | 27.70 USD | |
| 20 Apr 2020 | PURCHASE | Ventas, Inc. | 36 | 27.70 USD | |
| 26 Jan 2026 | SALE | Taysha Gene Therapies, Inc. | 41,312 | 4.61 USD | |
| 23 Jan 2026 | SALE | Taysha Gene Therapies, Inc. | 136,789 | 4.75 USD | |
| 12 Jan 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 1,008,000 | 0.00 USD | |
| 12 Jan 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 648,000 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Ventas, Inc. | 2,882 | 64.18 USD | |
| 02 Jan 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 892,500 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 892,500 | 0.00 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Ventas, Inc. | 3,648 | 47.96 USD | |
| 02 Jan 2024 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 1,184,688 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 1,184,688 | 0.00 USD | deriv |
| 14 Dec 2023 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 466,550 | 0.00 USD | deriv |
| 16 Aug 2023 | PURCHASE | Taysha Gene Therapies, Inc. | 444,444 | 0.90 USD | first after silence |
| 16 May 2023 | GRANT_AWARD | Ventas, Inc. | 3,835 | 45.63 USD | |
| 30 Dec 2022 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 1,106,131 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 15,500 | 0.00 USD | deriv |
| 27 Apr 2022 | GRANT_AWARD | Ventas, Inc. | 3,056 | 57.25 USD | |
| 17 Jun 2021 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 15,500 | 0.00 USD | deriv |
| 25 May 2021 | GRANT_AWARD | Ventas, Inc. | 3,158 | 0.00 USD | |
| 20 May 2021 | PURCHASE | Taysha Gene Therapies, Inc. | 1,170 | 22.35 USD | |
| 28 Sept 2020 | CONVERSION | Taysha Gene Therapies, Inc. | 1,601 | — |
1 purchase reported after at least 12 months of silence — most recent on 16 Aug 2023.